OAB-050: OCEAN (OP-103): a Phase 3, randomized, global, head-to-head comparison study of Melflufen and Dexamethasone (Dex) versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM)
Titel:
OAB-050: OCEAN (OP-103): a Phase 3, randomized, global, head-to-head comparison study of Melflufen and Dexamethasone (Dex) versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM)
Auteur:
Schjesvold, Fredrik Dimopoulos, Meletios-Athanasios Delimpasi, Sosana Robak, Pawef Coriu, Daniel Legiec, Wojciech Pour, Luděk Špička, Ivan Masszi, Tamás Doronin, Vadim Minarik, Jiri Salogub, Galina Alexeeva, Yulia Lazzaro, Antonio Maisnar, Vladimir Mikala, Gábor Moody, Victoria Thuresson, Marcus Byrne, Catriona Harmenberg, Johan Hájek, Roman Mateos, María-Victoria Richardson, Paul G. Sonneveld, Pieter